Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling

PHILADELPHIA, Sept. 02, 2026 (GLOBE NEWSWIRE) -- CMI Media Group, a leader in precision healthcare communications and WPP company (NYSE: WPP), announces the formal launch of a specialty communications business unit.

WPP is cutting up ​to 1,000 ‌more jobs by the year-end ​as the ​British advertising group ⁠accelerates a ​restructuring program under ​new chief Cindy Rose that will ​also ​offload non-core businesses and ‌additional ⁠properties, the Financial Times reported on Tuesday, ​citing ​people ⁠familiar with the ​matter.

WPP alleges in a legal filing that a former exec improperly leaked sensitive information in his lawsuit against the company. WPP is asking the court to seal several paragraphs, figures, and exhibits from the lawsuit.

I haven't published a review of the UK Dividend Stocks Portfolio since the end of 2024, so there's a fair bit to catch up on. The FTSE All-Share's recent strength has left my portfolio in the dust, and it now lags behind the All-Share on a total return basis over 1, 3, 5, and 10 years, and from inception. I think the portfolio's recent underperformance is a short-term issue, caused by four temporary headwinds that shouldn't have a long-term impact.

PHILADELPHIA, Aug. 17, 2026 (GLOBE NEWSWIRE) -- Strategic media healthcare agencies CMI Media Group - a WPP company (NYSE: WPP) - and Compas, are proud to be Certified™ by Great Place To Work® for the fourth year in a row. The prestigious recognition is based entirely on what current employees say about their experience working at CMI Media Group and Compas.

A new legal filing says Sony hired investigators to probe WPP's media rebate practices. Sony's review said that WPP ran a "global crime scheme" and improperly withheld rebates, the filing alleges.

PHILADELPHIA, Aug. 11, 2026 (GLOBE NEWSWIRE) -- CMI Media Group, a leading global healthcare media strategy, planning, innovation and buying agency and part of WPP (NYSE: WPP), today announced the formal launch of its Rare Disease Center of Excellence (COE). Designed to bridge the gap between niche boutique shops and large-scale media agencies, the Rare Disease COE delivers micro-precision audience strategy, tailored data integration, and high-touch execution tailored specifically to complex, low-incidence therapies.